[Pharmacokinetics and electrolyte balance following administration of furosemide in pregnant women with E gestosis].
In pregnant women with E-gestosis distribution and elimination of furosemid are significantly different to a non-pregnant control group. Furosemid guarantees a rapid and safe excretion of edemas. The efficiency of furosemid concerning electrolyte excretion is stronger in pregnant women with E-gestosis than in nonpregnant women. Therefore furosemide should be administered to pregnant women under intensive electrolyte control only.
D002118:Calcium / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism; D003404:Creatinine / Q000378:metabolism; D005260:Female; D005665:Furosemide / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D011188:Potassium / Q000378:metabolism; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000378:metabolism*; D011247:Pregnancy; D012964:Sodium / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy / Q000378:metabolism*
D002712:Chlorides; D014527:Uric Acid; D005665:Furosemide; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D002118:Calcium
Pharmakokinetik und Elektrolythaushalt nach Furosemidgabe bei Schwangeren mit E-Gestose.